Entera Bio Ltd
NASDAQ:ENTX
Entera Bio Ltd
Pre-Tax Income
Entera Bio Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Entera Bio Ltd
NASDAQ:ENTX
|
Pre-Tax Income
-$8.9m
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Pre-Tax Income
-$7m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Pre-Tax Income
$8.4m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
33%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Pre-Tax Income
-$60.6m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-14%
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Pre-Tax Income
-$98.3m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Pre-Tax Income
-₪31m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-12%
|
See Also
What is Entera Bio Ltd's Pre-Tax Income?
Pre-Tax Income
-8.9m
USD
Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Pre-Tax Income amounts to -8.9m USD.
What is Entera Bio Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
3%
Over the last year, the Pre-Tax Income growth was 31%. The average annual Pre-Tax Income growth rates for Entera Bio Ltd have been 8% over the past three years , 3% over the past five years .